日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Thermotoga neapolitana NH (3)-dependent NAD (+) synthetase CSB-YP495381TNL
CSB-EP495381TNL
CSB-BP495381TNL
CSB-MP495381TNL
CSB-EP495381TNL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermotoga neapolitana ATP-dependent protease ATPase subunit HslU (hslU) CSB-YP495382TNL
CSB-EP495382TNL
CSB-BP495382TNL
CSB-MP495382TNL
CSB-EP495382TNL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermotoga neapolitana Biotin synthase (bioB) CSB-YP495383TNL
CSB-EP495383TNL
CSB-BP495383TNL
CSB-MP495383TNL
CSB-EP495383TNL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari Ketol-acid reductoisomerase (ilvC) CSB-YP495384CZB
CSB-EP495384CZB
CSB-BP495384CZB
CSB-MP495384CZB
CSB-EP495384CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari 50S ribosomal protein L19 (rplS) CSB-YP495385CZB
CSB-EP495385CZB
CSB-BP495385CZB
CSB-MP495385CZB
CSB-EP495385CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari 50S ribosomal protein L28 (rpmB) CSB-YP495386CZB
CSB-EP495386CZB
CSB-BP495386CZB
CSB-MP495386CZB
CSB-EP495386CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari Probable transcriptional regulatory protein Cla_1081 (Cla_1081) CSB-YP495387CZB
CSB-EP495387CZB
CSB-BP495387CZB
CSB-MP495387CZB
CSB-EP495387CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari Succinyl-diaminopimelate desuccinylase (dapE) CSB-YP495388CZB
CSB-EP495388CZB
CSB-BP495388CZB
CSB-MP495388CZB
CSB-EP495388CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari Ribosomal protein L11 methyltransferase (prmA) CSB-YP495389CZB
CSB-EP495389CZB
CSB-BP495389CZB
CSB-MP495389CZB
CSB-EP495389CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari Phosphate acyltransferase (plsX) CSB-YP495390CZB
CSB-EP495390CZB
CSB-BP495390CZB
CSB-MP495390CZB
CSB-EP495390CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase CSB-YP495391CZB
CSB-EP495391CZB
CSB-BP495391CZB
CSB-MP495391CZB
CSB-EP495391CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari ATP-dependent Clp protease proteolytic subunit (clpP) CSB-YP495392CZB
CSB-EP495392CZB
CSB-BP495392CZB
CSB-MP495392CZB
CSB-EP495392CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari UPF0234 protein Cla_1551 (Cla_1551) CSB-YP495393CZB
CSB-EP495393CZB
CSB-BP495393CZB
CSB-MP495393CZB
CSB-EP495393CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari 30S ribosomal protein S20 (rpsT) CSB-YP495394CZB
CSB-EP495394CZB
CSB-BP495394CZB
CSB-MP495394CZB
CSB-EP495394CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari Diaminopimelate epimerase (dapF) CSB-YP495395CZB
CSB-EP495395CZB
CSB-BP495395CZB
CSB-MP495395CZB
CSB-EP495395CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari 30S ribosomal protein S3 (rpsC) CSB-YP495396CZB
CSB-EP495396CZB
CSB-BP495396CZB
CSB-MP495396CZB
CSB-EP495396CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari 50S ribosomal protein L6 (rplF) CSB-YP495397CZB
CSB-EP495397CZB
CSB-BP495397CZB
CSB-MP495397CZB
CSB-EP495397CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari Glycerol-3-phosphate acyltransferase (plsY), partial CSB-YP495398CZB1
CSB-EP495398CZB1
CSB-BP495398CZB1
CSB-MP495398CZB1
CSB-EP495398CZB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP495399CZB
CSB-EP495399CZB
CSB-BP495399CZB
CSB-MP495399CZB
CSB-EP495399CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari Bifunctional enzyme IspD/IspF (ispDF) CSB-YP495400CZB
CSB-EP495400CZB
CSB-BP495400CZB
CSB-MP495400CZB
CSB-EP495400CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×